Global Medical Aesthetics Market was valued at USD 11.42 Billion in 2020 and is anticipated to grow at USD 27.56 Billion by 2027 recording a CAGR of 10.7% during the forecast period 2021-2027. Medical Aesthetics Market: Medical aesthetic devices are used for the treatment of impairments related to a person’s physical appearance, such as slackness of the skin, an excess of fat, cellulite, wrinkles, moles, scars, unwanted hair, skin discoloration, liver spots and spider veins. Both non-surgical and surgical procedures and combination of both are included in aesthetic medicine in order to intensify the appearance of patient. Appropriate replacement of missing/ dysfunctional part of the body due to congenital disorders, trauma and accidents are also possible with aesthetic implants. Factors which are propelling the growth of medical aesthetics market such as rise in adaptation of minimal invasive & non-invasive processes, increase in awareness about cosmetic procedures & rise in demand for the treatment of aesthetic among male patients, growing brand consciousness on cosmetic and beauty products increasing aging population pool, and availability of aesthetic devices which are user-friendly. However, cost of the treatment is being very high, low reimbursements and malfunctions risk concerned with implants, strict regulations on the aesthetics procedures, survival rate is low because of high potency of competitors in the market are the few factors that are hindering growth of medical aesthetics market. The most general use of the aesthetic lasers are to treat skin and hair that includes rejuvenation of skin, tattoo removal and eliminate pigmented lesions. Due to the non-invasive features of the medical aesthetics, they procured high preference over the other devices among patients. Facial aesthetics are anticipated to report for the major share in medical aesthetics market due to the rising demand for facial the aesthetics and growing trends of non-invasive surgeries. Energy devices are anticipated to be as speedy growing segment of the market. Aesthetic practitioners have many choices of advanced instrumentations like flexible and soft needles, cannulas with blunt-tip and pen injectors for minimal invasive process. In October 2016, Merz Aesthetics, received U.S.FDA approval for Cellfina System used for treatment of cellulite on thighs and buttocks of females. In January, 2016, Allergan plc, received S.FDA approval for BOTOX (onabotulinumtoxinA) used to treat lower limb spasticity . In December, 2015, Merz Aesthetics, received U.S. FDA approval for Xeomin (incobotulinumtoxinA) to treat upper limb spasticity (ULS)



Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084


Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX